Series A Companies in Cambridge

Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.

ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.

Petragen is a biotechnology company spun out of Yale University and the NIH focused on novel therapies for periodontal disease

Tycho AI is an unmanned aerial vehicle technology (UAV) company building resilient navigation and AI systems for unmanned vehicles

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations.

Hosta Labs automates the analysis of images of interior property structures to provide in-depth property data and technical drawings.

Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.

Cumulus Digital Systems is a startup building an Internet of Tools-powered platform to make industrial facilities safer.

Hedron is building a network of data relay satellites that will link space and earth in real time.

Fermyon Technologies is a software development company that pioneers the next wave of cloud computing.

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

Expedition Medicines develops an AI-powered platform that creates small-molecule drugs for previously inaccessible disease targets.

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.

Carmine Therapeutics develops a novel type of gene therapy that utilizes extracellular vesicles produced in the laboratory.

Supplant is a biotechnology platform that makes sugar substitutes.